title: Identification of maturation-inducing steroid in a freshwater perch Anabas testudineus and differential responses of intact follicles and denuded oocytes to cyclic AMP in oocyte maturation.
abstract: Postvitellogenic follicles of freshwater perch Anabas testudineus incubated with [(3)H]pregnenolone as exogenous precursor produced several metabolites, including 17 alpha, 20 beta-dihydroxy-4-pregnen-3-one (DHP) and 5 beta-pregnane-3 alpha, 17 alpha,20 beta-triol (5 beta-3 alpha,17 alpha,20 beta-P). These were identified by chromatography, microchemical reactions, and crystallization to constant specific activity. Following stimulation with fish (perch) pituitary extract (FPE) there was significant high production of DHP and 5 beta-3 alpha,17 alpha,20 beta-P, concomitant with a high percentage of germinal vesicle breakdown (GVBD). Inhibitor of steroidogenesis (trilostane) and inhibitors of protein synthesis (cycloheximide and actinomycin-D) completely blocked FPE-induced pregnenolone metabolism and oocyte maturation. The effectiveness of various C(21) steroids in inducing GVBD was examined. Results indicate that DHP was the most potent inducer of GVBD than other structurally related C(21) steroids. In intact follicles, FPE-stimulated production of DHP was shown to be mediated through the adenylate cyclase-cAMP pathway. Addition of IBMX or forskolin, which increases the endogenous cAMP level, as well as directly supplementing dbcAMP to the incubation medium, had no inhibitory effect on DHP-induced GVBD in the intact follicles. But all these agents were shown to inhibit GVBD in fully denuded oocytes. This study provides evidence that DHP, produced by postvitellogenic follicles through the adenylate cyclase-cAMP pathway, is the maturation-inducing steroid in freshwater perch and that the role played by cAMP in the induction of GVBD in intact follicles is different from that in the denuded oocytes. J. Exp. Zool. 287:294-303, 2000.
authors.affiliation: Endocrinology Laboratory, Department of Zoology, Kalyani University, Kalyani, 741235, W. B. India.
authors.forename: S
authors.initials: S
authors.lastname: Bhattacharyya
authors.forename: U
authors.initials: U
authors.lastname: Sen
authors.forename: S P
authors.initials: SP
authors.lastname: Bhattacharyya
authors.forename: D
authors.initials: D
authors.lastname: Mukherjee
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000502:physiology*; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D006908:Hydroxyprogesterones / Q000378:metabolism*; D009865:Oocytes / Q000187:drug effects / Q000254:growth & development*; D009924:Organ Culture Techniques; D006080:Ovarian Follicle / Q000187:drug effects / Q000378:metabolism*; D010471:Perches / Q000502:physiology*; D011284:Pregnenolone / Q000378:metabolism
chemical_list: D006908:Hydroxyprogesterones; D013196:Dihydrotestosterone; C007433:17,20-dihydroxy-4-pregnen-3-one; D003609:Dactinomycin; D005576:Colforsin; D003994:Bucladesine; D011284:Pregnenolone; D003513:Cycloheximide; D000242:Cyclic AMP; C009954:trilostane; D015056:1-Methyl-3-isobutylxanthine